Watch VideoFederal health officials say AstraZeneca may have offered "outdated information" about its coronavirus vaccine.
In a statement Tuesday morning, the Data and Safety Monitoring Board said it was concerned the drug maker provided an "incomplete view" of efficacy data from a U.S. clinical trial.
On Monday,...
AstraZeneca COVID-19 Shot Raises Concerns
Newsy
0 shares
1 views
You might like
Related news coverage
Jonathan Emord, Biden’s Debate Audience Ban, Dem Convention Concerns, Inflation Crisis, Dr. Avery Jackson, Medical Freedom - T
Rumble
TODAY ON THE ROBERT SCOTT BELL SHOW: Jonathan Emord, Biden’s Debate Audience Ban, Dem Convention Concerns, Inflation Crisis,..
Advertisement
More coverage
UK '100% confident' in AstraZeneca jab after Germany suspends use in under-60s
Sky News
The UK is "100% confident in the efficacy" of the Oxford-AstraZeneca coronavirus vaccine, after Germany suspended its use in the..
-
EXPLAINER: What we know about AstraZeneca blood clot reports
SeattlePI.com
-
EXPLAINER: What we know about AstraZeneca blood clot reports
SeattlePI.com
-
Businessinsider.co.za | Germany suspends AstraZeneca vaccine for anyone under 60 due to concerns of blood clotting
News24
-
Germany halts AstraZeneca vaccine for people younger than 60 over clot concerns
Washington Post